Filter by
-
UMB Dataset
Substances nominated for inclusion on the 503B Bulks List: Dexamethasone Acetate
- Alternate Title(s)
- Dexamethasone Acetate: Summary Report
- Authors
- SeJeong YoonStephanie L. GianturcoLaura L. PavlechKathena D. Storm2 more author(s)...
- Description
The University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI), in collaboration with the Food and Drug Administration (FDA), conducted research and outreach to solicit input from the public, including medical specialists, to better understand the use of certain bulk drug substances nominated for use in compounding by outsourcing facilities under section 503B of the...
- Subject
-
Dexamethasone AcetateDrug CompoundingLegislation, DrugUnited States. Food and Drug Administration
- Access Rights
- Unrestricted access